Weight-Loss Drugs Cost Far More in US Than Other Nations

Aug. 17, 2023, 8:31 PM UTC

Sticker shock isn’t slowing Americans’ fervor for weight-loss drugs as a new analysis finds the drugs can cost five times as much — or more — in the US than they do elsewhere in the world.

A one-month supply of Ozempic, Novo Nordisk A/S’s diabetes drug that’s often used for weight loss, has a list price of $936 in the US, but just $169 in Japan, according to a report Thursday from the Kaiser Family Foundation and Peterson Center on Healthcare. It’s about ten times more expensive in the US than it is in Sweden, the United Kingdom, Australia ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.